Search
for
Sort by
Research 331–360 of 454
- Cronkhite–Canada syndrome: from clinical features to treatment
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Hidradenitis Suppurativa and Wound Management
- Weight Gain and Hair Loss during Anti-TNF Therapy
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- A “hair‐raising” history of alopecia areata
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Three Cases of Alopecia Following Clinical Islet Transplantation
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Cases Report the Cronkhite-Canada Syndrome
- Off-label uses of retinoids in dermatology
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Management of Serious Adverse Events Following Deoxycholic Acid Injection for Submental and Jowl Fat Reduction: A Systematic Review and Management Recommendations
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- Hidradenitis suppurativa: A comparison of guidelines